ESM1 and cancer: In addition to playing a significant role in the regulation of in vitro endothelial cell adhesion upon hypoxia, endocan was recognized as a novel endothelial marker for cancer and a new target for cancer therapy given its potential involvement in systemic inflammation, tumor-associated angiogenesis and cancer metastasis in vivo.